| Uncovering Listeria monocytogenes hypervirulence by harnessing its biodiversity MM Maury, YH Tsai, C Charlier, M Touchon, V Chenal-Francisque, ... Nature genetics 48 (3), 308-313, 2016 | 614 | 2016 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 498 | 2017 |
| Zika, chikungunya, and other emerging vector-borne viral diseases SC Weaver, C Charlier, N Vasilakis, M Lecuit Annual review of medicine 69 (1), 395-408, 2018 | 444 | 2018 |
| Evidence of a Role for Monocytes in Dissemination and Brain Invasion by Cryptococcus neoformans C Charlier, K Nielsen, S Daou, M Brigitte, F Chretien, F Dromer Infection and immunity 77 (1), 120-127, 2009 | 444 | 2009 |
| Cryptococcal cell morphology affects host cell interactions and pathogenicity LH Okagaki, AK Strain, JN Nielsen, C Charlier, NJ Baltes, F Chrétien, ... PLoS pathogens 6 (6), e1000953, 2010 | 397 | 2010 |
| Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? C Charlier, E Hart, A Lefort, P Ribaud, F Dromer, DW Denning, ... Journal of Antimicrobial Chemotherapy 57 (3), 384-410, 2006 | 264 | 2006 |
| Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier C Charlier, F Chrétien, M Baudrimont, E Mordelet, O Lortholary, F Dromer The American journal of pathology 166 (2), 421-432, 2005 | 260 | 2005 |
| Muscle resident macrophages control the immune cell reaction in a mouse model of notexin‐induced myoinjury M Brigitte, C Schilte, A Plonquet, Y Baba‐Amer, A Henri, C Charlier, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2010 | 226 | 2010 |
| Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients C Charlier, C Henegar, O Launay, C Pagnoux, A Berezne, B Bienvenu, ... Annals of the rheumatic diseases 68 (5), 658-663, 2009 | 173 | 2009 |
| Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis F Lanternier, S Poiree, C Elie, D Garcia-Hermoso, P Bakouboula, ... Journal of Antimicrobial Chemotherapy 70 (11), 3116-3123, 2015 | 168 | 2015 |
| Antifungal drugs during pregnancy: an updated review B Pilmis, V Jullien, J Sobel, M Lecuit, O Lortholary, C Charlier Journal of Antimicrobial Chemotherapy 70 (1), 14-22, 2015 | 161 | 2015 |
| Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era C Charlier, F Dromer, C Leveque, L Chartier, YS Cordoliani, A Fontanet, ... PloS one 3 (4), e1950, 2008 | 145 | 2008 |
| Arboviruses and pregnancy: maternal, fetal, and neonatal effects C Charlier, MC Beaudoin, T Couderc, O Lortholary, M Lecuit The Lancet Child & Adolescent Health 1 (2), 134-146, 2017 | 121 | 2017 |
| Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission A Cheret, C Bacchus-Souffan, V Avettand-Fenoël, A Mélard, G Nembot, ... Journal of Antimicrobial Chemotherapy 70 (7), 2108-2120, 2015 | 119 | 2015 |
| Preterm premature rupture of the membranes: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF) T Schmitz, L Sentilhes, E Lorthe, D Gallot, H Madar, M Doret-Dion, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 236, 1-6, 2019 | 112 | 2019 |
| Mixed Infections and In Vivo Evolution in the Human Fungal Pathogen Cryptococcus neoformans M Desnos-Ollivier, S Patel, AR Spaulding, C Charlier, D Garcia-Hermoso, ... MBio 1 (1), 10.1128/mbio. 00091-10, 2010 | 108 | 2010 |
| Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients Y Nguyen, A Flahault, N Chavarot, C Melenotte, M Cheminant, ... Clinical Microbiology and Infection 28 (12), 1654. e1-1654. e4, 2022 | 89 | 2022 |
| Maternal-neonatal listeriosis C Charlier, O Disson, M Lecuit Virulence 11 (1), 391-397, 2020 | 89 | 2020 |
| Determinants of non-vaccination against pandemic 2009 H1N1 influenza in pregnant women: a prospective cohort study R Freund, C Le Ray, C Charlier, C Avenell, V Truster, JM Tréluyer, ... PloS one 6 (6), e20900, 2011 | 86 | 2011 |
| PI3-kinase activation is critical for host barrier permissiveness to Listeria monocytogenes G Gessain, YH Tsai, L Travier, M Bonazzi, S Grayo, P Cossart, C Charlier, ... Journal of Experimental Medicine 212 (2), 165-183, 2015 | 77 | 2015 |
Marc LecuitInstitut Pasteur, Inserm, Université Paris Cité, Biology of Infection Unit在 pasteur.fr 的电子邮件经过验证
